A 52 year-old postmenopausal patient has evidence of low bone mineral density. She and her physician are considering therapy with raloxifene or a combination of conjugated estrogens and medroxyprogesterone acetate. Which of the following patient characteristics is MOST likely to lead them to select raloxifene?
Correct Answer: Strong family history of breast cancer
Description: -Raloxifene is a SERM used in post-menopausal osteoporosis due to its agonist action in bone. -It has additional advantage of causing decrease in risk of breast and endometrial cancer due to its estrogen antagonists action at these places. -Major adverse effect of raloxifene is thromboembolism and aggravation of hot flushes of menopause.
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now